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Regarding "Occluding aortic endoluminal stent graft 
combined with extra-anatomic axillofemoral bypass 
as alternative management of abdominal aortic 
aneurysms for patients at high risk with complex 
anatomic features: A preliminary report" 
To the Editors: 
To assess the usefulness of this report by Le Minh and 
colleagues (J Vasc Surg 1998;28:651-6), more informa-
tion on the patient selection is necessary. Simply having a 
short proximal neck (with no data on measurements) is 
now not a contraindication to endovascular repair of 
abdominal aortic aneurysms with either an anatomic bifur-
cated graft or the less anatomic aorta uni-iliac graft, espe-
cially with the use of uncovered suprarenal stents that take 
the attachment zone away from the seal zone. 
No information has been given for the diameter of the 
endoluminal graft/occluder introducer sheath. This was 
not a percutaneous procedure. If the occluding graft can be 
positioned just below the renal arteries, this implies that the 
vessels were not that tortuous. Therefore, why not simply 
deploy an aorta urn-iliac endovascular graft with a patent 
lumen. The extra anatomic bypass graft is therefore much 
shorter (ie, a femorofemoral crossover graft rather than an 
axillofemoral graft). 
Finally, no information is given as to the length of the 
procedure. Sick patients have a high mortality after long 
operations. 
Given these criticisms I can see no place for this tech-
nique in this endovascular era. 





We have read with interest the comments of Dr Stuart 
Walker_ 
Concerning the abdominal aortic aneurysm (AAA) 
proximal neck in our series, the average length was 12 ± 3 
mm (range, 5 to 25 mm), associated with an angulation 
from 0 degrees to 95 degrees (mean, 62 degrees). Short 
proximal neck «20 mm) associated or not to marked 
angulation has been shown to cause dislodgments of the 
stent graft followed by proximalleaks.l,2 
We agree that the use of uncovered suprarenal stents 
may prevent proximal endoleaks. However, in the study 
by Wain et al, l there were 21 % of endoleaks, despite the 
placing of proximal uncovered stents near or across the 
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renal arteries among patients with AAA treated with 
endovascular grafts. 
As mentioned in our article, the endoluminal graft 
introducer sheath had a diameter of 18F (internal diame-
ter 18F; length, 600; Balt Co. Montmarency, France) and 
was introduced on a super stiff guidewire via a femoral 
artery cut down. 
Tortuosity of iliac arteries does not preclude correct 
placing of the proximal part of the endograft beneath the 
renal arteries. In our experience, marked tortuosity of cal-
cified iliac arteries may provoke a kinking of the distal part 
of the endograft, resulting in cigar-shape formation with 
subsequent stenosis and thrombosis of the device_ 
The average length of time needed to implant the 
stent graft was 120 ± 30 minutes. The total length of the 
procedure (including axillofemoral bypass grafting) was 
175 ± 34 minutes. 
We emphasize the fact that this procedure is reserved 
for patients at high risk with short or angulated proximal 
neck associated or not with tortuous iliac arteries to ensure 
total exclusion of the AAA. 
Thuc Le Minh, MD 
Jean-Pierre Dereumc, MD 
Brussels, Belgium 
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Regarding "Percutaneous transluminal angioplasty 
for the treatment of limb threatening ischemia: Do 
the results justify an attempt before bypass grafting?" 
To the Editors: 
We read with interest the article by Parsons et al (J 
Vase Surg 1998;28:1066-71). The conclusions drawn by 
this article, namely that percutaneous transluminal angio-
plasty (PTA) is not considered to be a primary treatment 
in patients with infrainguinal disease and limb-threatening 
ischemia, should, we think, be qualified. 
The authors point out that the published reports of 
infrainguinal PTA in patients with threatened limbs have 
shown a range of results, with I-year patency ranging from 
12% to 70%. Our paper, which has been quoted in the arti-
cle1 actually shows a 24-month symptomatic patency rate of 
77% and a hemodynamic patency rate of 78%: The paper 
also quotes from our article that only 23% of all the critical-
ly ischemic patients were treated with percutaneous translu-
minal angioplasty. This indeed was true of the data that 
were collected between 1988 and 1991. We would like to 
refer you to our subsequent publications in which data was 
collected during a I-year period (1994)_2 A prospective 
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study carried out of 222 critically ischemic limbs in 188 
patients showed that PTA was used to treat 42% of the 
affected limbs and, during that same period, bypass grafting 
surgery was carried out in 24% of the limbs. Approximately 
80% of these angioplasties were infrainguinal. 
A further prospective 12-month follow-up study of these 
188 patients with critical limb ischemia was carried out to 
assess the efficacy of PTA and surgery.3 Revascularisation 
with either surgery or PTA achieved the same limb salvage 
rate of76% at 12 months. 
Our extensive experience with subintimal angioplasty in 
the infrainguinal and the infrapopliteal arteries together 
with the excellent patency results that have been achieved 
for the treatment of patients with occlusive disease and crit-
ical ischemia has reinforced our view that a large proportion 
of patients with severe chronic lower limb ischemia can be 
managed with PTA. This management strategy produces a 
clinically effective outcome at 1 year that is similar for both 
bypass grafting surgery and PTA in patients with critical 
limb ischemia. Our present policy in patients with chronic 
critical limb ischemia is to have an attempt at PTA in the 
first instance in the vast majority of cases. It is primarily suc-
cessful in more than 90% of the cases (in fact, 95.4% of cases 
in the referred articles). 
We believe that, at the present time, two thirds of our 
patients with severe chronic critical limb ischemia are 
effectively treated with angioplasty, and we would have no 
hesitation in recommending angioplasty as the primary 
treatment method for this condition. 
Peter R.F. Bell, MD, FRCS 
Amman Bolia, MBChB, FRCR 
University of Leicester 
Leicester Royal Infirmary 
Leicester, England 
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Reply 
We appreciate the comments of Drs Bell and Bolia 
regarding their results with subintimal angioplasty for crit-
ical leg ischemia. We are aware of their work and applaud 
the results they have reported. We have enthusiastically 
tried to reproduce their results but cannot because of 
either different patient groups or different technical exper-
tise. We would like to note that, in the paper cited in their 
letter, only 42% of patients with ischemia underwent treat-
ment with angioplasty and 24% underwent surgery. An 
additional 27% of the patients underwent conservative 
treatment or had amputations. This percentage of the 
patients who underwent these treatments is larger than we 
would see in our own experience. 1 Review of the 12-
month prospective study did not mention patency rate, 
although the 12-month limb salvage rates were equiva-
lent.2 A paper regarding subintimal angioplasty of 
infrapopliteal occlusions, in which 32 lesions were treated 
in 28 limbs with critical ischemia, had a 12-month paten-
cy rate of 53%.3 
We would like to point out that the purpose of our 
paper was to review the results of standard of angioplas-
ty in our own patients. We believe that a result of stan-
dard angioplasty in patients with critical ischemia was not 
sufficiently durable to serve as a primary treatment 
method. 
Only time and reports from other groups interested in 
limb salvage will answer the question of which approach is 
better suited for these difficult cases. 
William D. Suggs, MD 
Frank]. Veith, MD 
New¥ork, NY 
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